Oliver Luxxe Assets LLC

Position in JAZZ — Jazz Pharmaceuticals plc

CIK 1666239 GLADSTONE, NJ

Position in JAZZ

as of Jun 30, 2026 · filed Jul 9, 2026 Compact

Position Value

$4,544,694

+$943,292 QoQ

Shares Held

18,860

-1.0% QoQ

Ownership

0.030%

of shares outstanding

% of Portfolio

0.75%

of 13F equity value

Holder Rank

#11

of 63 holders

Holding Since

Jun 2022

3 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Jun 30, 2026

Oliver Luxxe Assets LLC holds $10,072,172 across 5 Biotechnology names. JAZZ ranks #1 (45.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JAZZ	Jazz Pharmaceuticals plc This page	18,860	$4,544,694
2	HALO	Halozyme Therapeutics, Inc.	33,014	$2,584,005
3	CPRX	Catalyst Pharmaceuticals, Inc.	49,744	$1,563,453
4	INVA	Innoviva, Inc.	58,957	$1,338,913
5	GANX	Gain Therapeutics, Inc.	20,250	$41,107

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,544,694	18,860	-1.0%	Shares	Sole	2026-07-09
2026-03-31	$3,601,402	19,050	+63.5%	Shares	Sole	2026-04-08
2022-06-30	$1,817,360	11,649	—	Shares	Sole	2022-08-15
No filing history on record for this holder in this stock.